Skip to content

The clinical use of remote parameter testing based on 5G cloud technology supported platform in CIED implantation procedures: a single center, randomized, open-label study

The clinical use of remote parameter testing based on 5G cloud technology supported platform in CIED implantation procedures: a single center, randomized, open-label study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057587
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases

Interventions

Control group:Parameter testing beside operating table
Remote group:Remote parameter testing

Sponsors

The Third People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. Accepting CIED (St. Jude) implantation patients; 3. Those who have signed the informed consent of this study.

Exclusion criteria

Exclusion criteria: 1. Patients with the slowest ventricular rate < 30 beats per minute before implantation.

Design outcomes

Primary

MeasureTime frame
Radiation dose and duration;The operation time;Frequency of opening the door;Frequency and total duration of the parameters test;Fommunication problems, signal interruption etc.;Satisfaction with the use of remote parameters testing;

Countries

China

Contacts

Public ContactShiqiang Xiong

The Third People's Hospital of Chengdu

xionglliu@163.com+86 19980510703

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026